Collectively, the data establish a pathogenic model wherein Tregs undergo phenotypic reprogramming within the MASLD microenvironment, driving CD29 upregulation to promote cellular adhesion and accelerate the MASH‐to‐HCC transition via integrin‐mediated signalling cascades. Here, ITGB1 is linked to hepatocellular carcinoma.